Doxanano

Doxanano is dedicated to advancing pharmaceutical manufacturing, specifically focused on revolutionizing chemotherapy treatments for patients battling solid tumors. Doxanano is committed to significantly enhancing the targeted delivery of chemotherapeutic agents directly to tumors, while simultaneously minimizing adverse effects on healthy organs. Located at 2 All. du Doyen Georges Brus, Pessac, 33600, FR, Doxanano specializes in leveraging the unique attributes of our DXN polymersomes drug delivery platform, integrated with the precision of radiotherapy.

At Doxanano, the goal is to provide cutting-edge solutions that redefine the landscape of cancer treatment. Doxanano focuses on innovation and excellence in pharmaceutical manufacturing, driving progress towards more effective and less harmful therapies. The company’s work embodies a commitment to improving patient outcomes and quality of life.

The team at Doxanano is constantly working to refine its technologies and broaden its impact. To ensure the most accurate and complete information is available, further details about Doxanano's advanced pharmaceutical manufacturing capabilities and achievements will be updated soon with the support of the company’s management.

Manager, we invite you to create a customized and exclusive company showcase and product listing on our platform to further highlight Doxanano's innovative work.